Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Cusack

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Clinical Pharmacology|January 1, 1987
Evaluation of a proposed method for phenytoin maintenance dose prediction following an intravenous loading doseJ J Crowley, J R Koup, B J Cusack, et al.
British Journal of Pharmacology|November 1, 1993
Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile functionP S Mushlin, B J Cusack, R J Boucek, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbitB J Cusack, S P Young, V L Loseke, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2006
Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolismB J Cusack, H Gambliel, B Musser, et al.
Biochemical Pharmacology|February 15, 1990
Taurine deficiency and doxorubicin: interaction with the cardiac sarcolemmal calcium pumpH Harada, B J Cusack, R D Olson, et al.
Toxicology and Applied Pharmacology|February 1, 1993
Daunorubicin-induced cardiac injury in the rabbit: a role for daunorubicinol?B J Cusack, P S Mushlin, L D Voulelis, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1988
Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy menJ J Crowley, B J Cusack, S G Jue, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbitB J Cusack, D A Tesnohlidek, V L Loseke, et al.
The Journal of Clinical Investigation|April 1, 1993
Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit modelD A Dodd, J B Atkinson, R D Olson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinolR D Olson, P S Mushlin, D E Brenner, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Clinical Pharmacology|January 1, 1987
Evaluation of a proposed method for phenytoin maintenance dose prediction following an intravenous loading doseJ J Crowley, J R Koup, B J Cusack, et al.
British Journal of Pharmacology|November 1, 1993
Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile functionP S Mushlin, B J Cusack, R J Boucek, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbitB J Cusack, S P Young, V L Loseke, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2006
Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolismB J Cusack, H Gambliel, B Musser, et al.
Biochemical Pharmacology|February 15, 1990
Taurine deficiency and doxorubicin: interaction with the cardiac sarcolemmal calcium pumpH Harada, B J Cusack, R D Olson, et al.
Toxicology and Applied Pharmacology|February 1, 1993
Daunorubicin-induced cardiac injury in the rabbit: a role for daunorubicinol?B J Cusack, P S Mushlin, L D Voulelis, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1988
Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy menJ J Crowley, B J Cusack, S G Jue, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbitB J Cusack, D A Tesnohlidek, V L Loseke, et al.
The Journal of Clinical Investigation|April 1, 1993
Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit modelD A Dodd, J B Atkinson, R D Olson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinolR D Olson, P S Mushlin, D E Brenner, et al.
Pageof 4